Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries|Anna Francis, Vivekanand Jha, Vivek Kumar et al.|Kidney International|2022Cited by 66
International practice patterns of dyslipidemia management in patients with chronic kidney disease under nephrology care: is it time to review guideline recommendations?Viviane Cálice-Silva, Jarcy Zee|Lipids in Health and Disease|2023Cited by 15
Nurturing Global Leadership, Advocacy, Research, and Collegiality: The Unique Experience of The International Society of Nephrology Emerging Leaders ProgramSabine Karam, Rahul Chanchlani, Muhammad Iqbal Abdul Hafidz et al.|Kidney International Reports|2023Cited by 1
Access to and Barriers to Access for Essential Medicines in Nephrology and Related Non-Communicable Diseases: A Scoping Review ProtocolMichelle Wong, Vivekanand Jha, Viviane Cálice-Silva et al.|Research Square|2021Cited by 0
POS-327 BARRIERS TO ACCESSING ESSENTIAL MEDICINES FOR KIDNEY DISEASE: AN INTERNATIONAL SURVEYAnna Francis, Vivekanand Jha, T. Chen et al.|Kidney International Reports|2022Cited by 0